30 Day Trial

U.S. Spinal Hardware Sales Continues to Drive NuVasive Growth

Share:

NuVasive reports 3Q19 revenue of USD $290.8MM, +7.2% vs. 3Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.